Browsing Tag
Modus Therapeutics funding
1 post
Modus Therapeutics secures $15.7m for sickle cell disease drug development
Modus Therapeutics, a Swedish biotech firm specializing in sickle cell disease therapies, has successfully raised SEK 140 million…